Dog Myasthenia Gravis and Neuromuscular Welfare

Myasthenia gravis is an acquired or congenital autoimmune neuromuscular disease in dogs causing progressive muscle weakness and dysphagia, with significant welfare implications requiring careful long-term management.

Key Facts

Myasthenia gravis (MG) involves autoantibodies against acetylcholine receptors at the neuromuscular junction
Golden Retrievers, German Shepherds, and Labrador Retrievers are among predisposed breeds for acquired MG
Megaesophagus — generalised esophageal dilation causing regurgitation — is the most common presentation in dogs
Aspiration pneumonia from regurgitation is the leading cause of death in MG dogs
Diagnosis involves acetylcholine receptor antibody titre (AChR-Ab) testing and response to edrophonium challenge
Pyridostigmine treatment improves neuromuscular transmission — remission occurs in approximately 50 percent of dogs within 6 months

Welfare Considerations

Myasthenia gravis causes significant welfare suffering through progressive weakness affecting normal activity, and particularly through megaesophagus and the repeated regurgitation that is both distressing for the dog and uncomfortable. The aspiration pneumonia risk from inhaling regurgitated material is life-threatening and represents the most serious welfare concern. Managing MG with megaesophagus requires innovative feeding approaches — the Bailey chair (a specialised sitting position that uses gravity to aid esophageal transit) is a welfare-positive management innovation that significantly reduces regurgitation and aspiration risk. Regular monitoring for aspiration pneumonia, prompt antibiotic treatment, and dedicated owner commitment are essential for maintaining welfare in MG dogs.

What You Can Do

Invest in a Bailey chair or similar vertical feeding position if your dog with MG has megaesophagus — it dramatically reduces aspiration risk
Feed small, frequent meals of appropriate texture (often gruel consistency) to minimise regurgitation volume
Monitor for aspiration pneumonia signs — increased respiratory rate, cough, and fever require immediate veterinary assessment
Discuss remission monitoring with your vet — AChR-Ab titres can guide medication tapering when remission approaches